MedTrace Logo

Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma

NCT01606605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2013-01-15

No results posted yet for this study

Summary

The investigators perform a retrospective microarray gene expression profiling study of FFPE from a cohort of DLBCL patients with whole genome cDNA mediated Annealing Selection and Ligation (WG-DASL) assay. The investigators also study the pattern of microRNA from patients with diffuse large B-cell lymphoma. The results of gene expression profiles and microRNA is correlated with clinical outcomes of diffuse large B-cell lymphoma.

Conditions

  • Diffuse Large B-cell Lymphoma

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Won Seog Kim, MD, PhD · Samsung Medical Center Cancer Research Institute

Eligibility

Min Age
15 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01606605 on ClinicalTrials.gov